TNFSF10 and neoplasm: The EGFR-targeted TRAIL fusion protein scFv425:sTRAIL simultaneously blocks EGFR-mitogenic signaling, thereby sensitizing tumor cells to apoptosis through the TRAIL-receptor signaling in the A172 glioblastoma cell line [330].